Skip to content

Relevance of Recording an ECG Trace With a Connected Watch

Feasibility and Diagnostic Relevance of Recording an ECG Trace With a Connected Watch

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06272396
Acronym
ECG-MC
Enrollment
3000
Registered
2024-02-22
Start date
2024-03-26
Completion date
2028-03-26
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac

Keywords

Electrocardiogram, Smart watch, Arrhythmia, Artificial Intelligent, Remote monitoring

Brief summary

Over the past few years, various systems have been developed to record ECG traces on an ambulatory basis. The latest connected watch models feature 2-electrode ECG recording. This single (1D) or six derivations (6D) can be used to derive a wealth of information about the heart's rhythm. The information that can be derived from an ECG recording with a derivation goes far beyond̀ simple differentiation between atrial fibrillation and sinus rhythm. In contrast, in various clinical situations, a tracing restricted to an intracardiac defibrillator (ICD) may prove falsely normal, wrongly reassuring a patient and delaying management. The primary objective of the study is to evaluate the sensitivity of ECG-1D or 6D recordings from a connected watch in measuring electrical parameters, compared with a standard ECG-12D, also to obtain a bank of tracings, to create and validate an artificial intelligence algorithm for the automatic analysis of ECG tracings recorded with a connected watch and also to validate the feasibility and sensitivity of recording an ECG tracing with a connected watch in children.

Detailed description

Single-arm prospective study to evaluate the measurement of electrocardiographic parameters obtained using two non-invasive ECG methods, one 12-lead reference method and the second 1 or 6 leads recorded from a connected watch, in a group of patients with healthy hearts (normal ECG) and 19 pathological groups.

Interventions

ECG 1D/6D

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients hospitalized or seen in consultation in one of the departments of the Haut Lévêque cardiology hospital, * Patient of both sexes, minor (from birth to 18 years) or adult, * Free, informed and written consent from the patient or, in the case of minors, from the legal parent (at the latest on the day of inclusion and before any examination required for the research), * Subject affiliated to or benefiting from a social security regime.

Exclusion criteria

* Person incapable of giving consent, * Person subject to a legal protection measure (safeguard of justice, tutorship or curatorship), * A person deprived of liberty by judicial or administrative decision.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of electrical parameters measured using the 2 ECG methods: QT/QTc36 monthsMean of QT/QTc (corrected QT) intervals
Comparison of electrical parameters measured using the 2 ECG methods: P-wave amplitude36 monthsMean of P-wave amplitude
Comparison of electrical parameters measured using the 2 ECG methods: P-wave duration36 monthsMean of P-wave duration
Comparison of electrical parameters measured using the 2 ECG methods: QRS amplitude36 monthsMean of QRS amplitude
Comparison of electrical parameters measured using the 2 ECG methods: QRS duration36 monthsMean of QRS duration

Secondary

MeasureTime frameDescription
Creation of bank of anormal ECG trace36 monthsNumber of ECG-1D/6D and 12 derivations
Compare the diagnostic capabilities of an ECG trace recorded with a watch against the reference method, the 12-lead ECG36 monthsAccuracy of diagnostic
Validate the feasibility of recording and sending of ECG tracings with a connected watch at the patient's home36 monthsNumber of ECG-1D/6D and 12 derivations
Validate the feasibility of recording an ECG trace with a connected watch for a child36 monthsNumber of ECG-1D/6D and 12 derivations
Validate the sensibility of an ECG trace with a connected watch for a child36 monthsQuality of ECG-1D/6D

Countries

France

Contacts

Primary ContactPierre BORDACHAR
pierre.bordachar@chu-bordeaux.fr+335 57 65 64 71

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026